E-LIB Suche - Ergebnisse für: Brossa, V.

1

P1174Impact of sex-differences in long-term outcomes with c..:

Moreno Weidmann, Z L ; Alonso-Martin, C ; Mendez-Zurita, F...
EP Europace. 22 (2020) Supplement_1 - p. , 2020

Link: https://doi.org/10.1093/..

2

Urinary chlorine: a potential biomarker of diuretic resista..:

Zegri Reiriz, I ; Garcia-Coscuella, D ; Moreno, T...
European Heart Journal. 41 (2020) Supplement_2 - p. , 2020

Link: https://doi.org/10.1093/..

3

P3378Is sidenafil treatment associated with higher rate of ..:

Sole Gonzalez, E. ; Capellades-Olivella, H. ; Mirabet, S....
European Heart Journal. 38 (2017) suppl_1 - p. , 2017

Link: https://doi.org/10.1093/..

4

Prognostic Value of High-Sensitivity Troponin-T to Identify..:

Méndez, A.B. ; Ordonez-Llanos, J. ; Mirabet, S....
Transplantation Proceedings. 48 (2016) 9 - p. 3021-3023 , 2016

Link: https://doi.org/10.1016/..

5

De Novo Anti-HLA Antibodies After Heart Transplantation Are..:

Solé-González, E. ; Mirabet, S. ; Brossa, V....
Transplantation Proceedings. 48 (2016) 9 - p. 3030-3032 , 2016

Link: https://doi.org/10.1016/..

6

Health‐related quality of life, social support, and caregiv..:

Delgado, J.F. ; Almenar, L. ; González‐Vilchez, F....
Clinical Transplantation. 29 (2015) 9 - p. 771-780 , 2015

Link: https://doi.org/10.1111/..

7

Role of Vascular Disease in the Evolution of Heart Transpla..:

Bos, L. ; Mirabet, S. ; Brossa, V....
Transplantation Proceedings. 47 (2015) 8 - p. 2393-2394 , 2015

Link: https://doi.org/10.1016/..

8

Cost-Effectiveness of Highly Sensitive Cardiac Troponin T t..:

Méndez, A.B. ; Ordonez-Llanos, J. ; Farrero, M....
Transplantation Proceedings. 47 (2015) 8 - p. 2395-2396 , 2015

Link: https://doi.org/10.1016/..

9

RAndomized Comparison of raDIal vs. femorAL Access for Rout..:

Scalone, G. ; Brugaletta, S. ; Martín-Yuste, V....
Transplantation Proceedings. 46 (2014) 10 - p. 3262-3267 , 2014

Link: https://doi.org/10.1016/..

10

Prognostic implications of positive C4d Immunostaining on e..:

Mirabet, S. ; Roldan, C. ; Rivas, M....
European Heart Journal. 34 (2013) suppl 1 - p. P5098-P5098 , 2013

Link: https://doi.org/10.1093/..

11

Correlation of Immunological Markers With Graft Vasculopath..:

Roldán, C. ; Mirabet, S. ; Brossa, V....
Transplantation Proceedings. 44 (2012) 9 - p. 2653-2656 , 2012

Link: https://doi.org/10.1016/..

12

Assessment of Immunological Markers as Mediators of Graft V..:

Mirabet, S. ; Gelpí, C. ; Roldán, C....
Transplantation Proceedings. 43 (2011) 6 - p. 2253-2256 , 2011

Link: https://doi.org/10.1016/..

13

The Prognosis of Noncutaneous, Nonlymphomatous Malignancy A..:

Crespo-Leiro, M.G. ; Alonso-Pulpón, L.A. ; Villa-Arranz, A....
Transplantation Proceedings. 42 (2010) 8 - p. 3011-3013 , 2010

Link: https://doi.org/10.1016/..

14

Steroid Use in Heart Transplant Patients in Spain in the Cu..:

Crespo-Leiro, M. ; Delgado, J. ; Almenar, L....
Transplantation Proceedings. 41 (2009) 6 - p. 2244-2246 , 2009

Link: https://doi.org/10.1016/..

15

Malignancy After Heart Transplantation: Incidence, Prognosi..:

Crespo-Leiro, M.G. ; Alonso-Pulpón, L. ; Vázquez de Prada, J.A....
American Journal of Transplantation. 8 (2008) 5 - p. 1031-1039 , 2008

Link: https://doi.org/10.1111/..